Angiotensin-Converting Enzyme Inhibitors Increase Vasoconstrictor Requirements After Cardiopulmonary Bypass

This publication has 25 references indexed in Scilit:

• Can selective digestive decontamination avoid the endotoxemia and cytokine activation promoted by cardiopulmonary bypass?
  Critical Care Medicine, 1993
• Down-Regulation and Desensitization of the ??-Adrenergic Receptor System of Human Lymphocytes After Cardiac Surgery
  Anesthesia & Analgesia, 1993
• Angiotensin converting enzyme inhibitors. I. Pharmacology
  American Heart Journal, 1988
• Book ReviewHuman Gene Therapy
  New England Journal of Medicine, 1988
• <α>1-Adrenergic Responsiveness during Coronary Artery Bypass Surgery
  Anesthesiology, 1988
• Changes in plasma atrial natriuretic peptide — immunoreactivity in patients undergoing coronary artery bypass graft placements
  Regulatory Peptides, 1987
• What is the value of home blood pressure measurement in patients with mild hypertension?
  Hypertension, 1984
• Effects of captopril and enalapril on regional vascular resistance and reactivity in spontaneously hypertensive rats.
  Hypertension, 1983
• Separation of human brain angiotensin-converting enzyme from enkephalin-degrading activity
  European Journal of Pharmacology, 1979
• Peripheral vascular resistance and angiotensin II levels during pulsatile and no-pulsatile cardiopulmonary bypass.
  Thorax, 1979